Need a refresh on the current regulatory landscape for GI oncology? We've got you covered. Here's everything that moved the needle across GI malignancies this month.
Commentary|Videos|December 17, 2025
Colorectal Cancer: Past, Present, Future
Author(s)Nicholas James Hornstein, MD, PhD
Nicholas James Hornstein, MD, PhD, discusses the past, present, and future of colorectal cancer management.
Advertisement
Nicholas James Hornstein, MD, PhD, discusses the past, present, and future of colorectal cancer management.
Advertisement
Related to this article
In a recent OncLive Peer Exchange, expert investigators discussed the utility of ctDNA and MRD testing in solid tumors.
The European Union approved trastuzumab deruxtecan for previously treated, HER2-postive metastatic solid tumors.
The STELLAR-303 trial met its OS end point with the zanzalintinib regimen in the ITT population but failed to show the same benefit in the NLM subgroup.
Advertisement
Advertisement
Trending on OncLive
1
Divesiran Reduces Phlebotomy Burden and Improves Iron Stores in Polycythemia Vera
2
The OncFive: Top Oncology Articles for the Week of 6/28
3
Luspatercept Sustains Long-Term Transfusion Independence, Favorable OS Trend in ESA-Naive Lower-Risk MDS
4
FDA Grants Breakthrough Device Designation to Merlin CP-GEP for Early-Stage Melanoma Risk Stratification
5